G lobal R egistry of A dverse C linical E vents (GRACE © ): A Prospective, Multicenter, Observational Cohort Evaluating Complications Associated With Aesthetic Injectables
Journal of Cutaneous Medicine and Surgery · 2025
DOI: 10.1177/12034754241311270 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Cutaneous Medicine and Surgery, 2025. Verfasst von Kaitlyn M Enright und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Surgery, McGill University, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Registries, Cosmetic Techniques, Dermal Fillers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds de Recherche du Québec - Santé.
Abstract (Originalsprache)
Background
A review of Health Canada’s post-market surveillance database has revealed that the reporting of adverse events (AEs) following aesthetic injectable treatments is significantly underreported. To increase reporting, investigators have recently developed a novel Electronic Data Capture system: The Global Registry of Adverse Clinical Events (GRACE © ).
Objective
To identify the incidence of AEs associated with aesthetic injectable treatments.
Methods
Aesthetic clinicians from 10 Canadian sites were recruited. Demographic and clinical data were recorded within the database, which included over 45 patient variables.
Results
Throughout the active phase of the trial (duration: 27 months), 123,124 injectable treatments were conducted. One hundred and eleven patients, experiencing a total of 235 AEs, were entered into the portal. This equated to an AE incidence rate of 0.19%, per treatment. Thirty unique products were associated with AEs. In total, there were 112/235 (47.66%) mild, 88/235 (37.45%) moderate, and 35/235 (14.90%) severe AEs. The most common complication (n = 48/235; 20.43%) was swelling, with a prevalence of 0.04%. Of the documented AEs, only 5 were reported to other sources, including 1 case being reported to Health Canada and 4 cases to the respective product manufacturer.
Conclusions
The initial feasibility of a registry assessing safety outcomes following injectable treatment has been demonstrated. Findings support that the implementation of the GRACE Portal is an effective outreach strategy for increasing AE reporting by health care professionals. The data represent a more accurate depiction of the safety profile of approved aesthetic injectables in Canada.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Surgery, McGill University, Montreal, QC, Canada.
- Clinical Research Unit, Erevna Innovations Inc, Montreal, QC, Canada.
- Division of Plastic Surgery, McGill University, Montreal, QC, Canada.
- Division of Surgical Research, Head Surgical Epidemiology, McGill University, Montreal, QC, Canada.
- JSS Medical Research, Montreal, QC, Canada.
ORCID-Profile: Kaitlyn M Enright
Förderung
- Fonds de Recherche du Québec - Santé
Zitieren
APA
Enright, K. M., Nikolis, A., & Sampalis, J. (2025). G lobal R egistry of A dverse C linical E vents (GRACE © ): A Prospective, Multicenter, Observational Cohort Evaluating Complications Associated With Aesthetic Injectables. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754241311270
Vancouver
Enright KM, Nikolis A, Sampalis J. G lobal R egistry of A dverse C linical E vents (GRACE © ): A Prospective, Multicenter, Observational Cohort Evaluating Complications Associated With Aesthetic Injectables. Journal of Cutaneous Medicine and Surgery. 2025. doi:10.1177/12034754241311270
BibTeX
@article{Enright2025,
author = {Enright, Kaitlyn M and Nikolis, Andreas and Sampalis, John},
title = {G lobal R egistry of A dverse C linical E vents (GRACE © ): A Prospective, Multicenter, Observational Cohort Evaluating Complications Associated With Aesthetic Injectables},
journal = {Journal of Cutaneous Medicine and Surgery},
year = {2025},
doi = {10.1177/12034754241311270}
}
EUVIMED